Use of palivizumab is underestimated in the Swedish Prescribed Drug Register – implications for register-based drug studies
Marie Linder,1 Camilla Byström,1 Helle Kieler,1 Gunnar Bergman,2 Ann Haerskjold3,4 1Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden; 2Stockholm-Uppsala Department of Pediatric Cardiology, Astrid Lindgren Children's Hospital,...
Main Authors: | Linder M, Byström C, Kieler H, Bergman G, Haerskjold A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-12-01
|
Series: | Clinical Epidemiology |
Online Access: | http://www.dovepress.com/use-of-palivizumab-is-underestimated-in-the-swedish-prescribed-drug-re-peer-reviewed-article-CLEP |
Similar Items
-
Drug use during pregnancy in Sweden – assessed by the Prescribed Drug Register and the Medical Birth Register
by: Tobias Svensson, et al.
Published: (2011-02-01) -
Children with hemodynamically significant congenital heart disease can be identified through population-based registers
by: Bergman G, et al.
Published: (2015-01-01) -
Which Medication Is the Patient Taking at Admission to the Emergency Ward? Still Unclear Despite the Swedish Prescribed Drug Register.
by: Ida Engqvist, et al.
Published: (2015-01-01) -
Does the number of siblings affect health in midlife? Evidence from the Swedish Prescribed Drug Register
by: Anna Baranowska-Rataj, et al.
Published: (2016-11-01) -
The Nordic health registers – an important source when evaluating the safety of antidepressants during pregnancy
by: Helle Kieler
Published: (2010-08-01)